Aripiprazole: a partial dopamine D2 receptor agonist antipsychotic

By Keck Jr Paul E   McElroy Susan L  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 4, 2003-04 ,pp. : 655-662

Informa Healthcare

Access to resources Recommend Favorite

Interaction of the novel antipsychotic aripiprazole with 5-HT_1A and 5-HT_2A receptors: functional receptor-binding and in vivo electrophysiological studies

By Stark Arlene   Jordan Shaun   Allers Kelly   Bertekap Robert   Chen Ruoyan   Mistry Kannan Tanaz   Molski Thaddeus   Yocca Frank   Sharp Trevor   Kikuchi Tetsuro   Burris Kevin  

Psychopharmacology, Vol. 190, Iss. 3, 2007-02 ,pp. : 373-382

Springer Publishing Company

Access to resources Recommend Favorite

Aripiprazole (OPC-14597) fully substitutes for the 5-HT_1A receptor agonist LY293284 in the drug discrimination assay in rats

By Marona-Lewicka Danuta   Nichols David  

Psychopharmacology, Vol. 172, Iss. 4, 2004-04 ,pp. : 415-421

Springer Publishing Company

Access to resources Recommend Favorite

GR127935 acts as a partial agonist at recombinant human 5-HT 1D and 5-HT 1D receptors

By Watson J.M.   Burton M.J.   Price G.W.   Jones B.J.   Middlemiss D.N.  

European Journal of Pharmacology, Vol. 314, Iss. 3, 1996-10 ,pp. : 365-372

Elsevier

Access to resources Recommend Favorite

5-HT 1A receptor agonist properties of the antipsychotic, nemonapride: comparison with bromerguride and clozapine

By Assie M.-B.   Cosi C.   Koek W.  

European Journal of Pharmacology, Vol. 334, Iss. 2, 1997-09 ,pp. : 141-147

Elsevier

Access to resources Recommend Favorite